Gland Pharma Financial Statements

Gland Pharma Annually Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 - -
Growth matrix (%)        
Revenue growth 31.50 -- -- --
Op profit growth 36.30 -- -- --
EBIT growth 33.80 -- -- --
Net profit growth 29 -- -- --
Profitability ratios (%)        
OPM 37.60 36.30 -- --
EBIT margin 38.60 38 -- --
Net profit margin 28.80 29.40 -- --
RoCE 27.50 -- -- --
RoNW 5.22 -- -- --
RoA 5.13 -- -- --
Per share ratios ()        
EPS 60.90 49.90 -- --
Dividend per share -- -- -- --
Cash EPS 54.90 43.80 -- --
Book value per share 361 235 -- --
Valuation ratios        
P/E 40.70 -- -- --
P/CEPS 45.10 -- -- --
P/B 6.87 -- -- --
EV/EBIDTA 26.10 -- -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (25) (22) -- --
Liquidity ratios        
Debtor days 67.10 -- -- --
Inventory days 107 -- -- --
Creditor days (58) -- -- --
Leverage ratios        
Interest coverage (392) (139) -- --
Net debt / equity (0.50) (0.40) -- --
Net debt / op. profit (2.30) (1.40) -- --
Cost breakup ()        
Material costs (43) (42) -- --
Employee costs (9) (11) -- --
Other costs (10) (11) -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 - -
Revenue 3,463 2,633 -- --
yoy growth (%) 31.50 -- -- --
Raw materials (1,492) (1,102) -- --
As % of sales 43.10 41.90 -- --
Employee costs (311) (278) -- --
As % of sales 8.99 10.50 -- --
Other costs (357) (298) -- --
As % of sales 10.30 11.30 -- --
Operating profit 1,302 955 -- --
OPM 37.60 36.30 -- --
Depreciation (99) (95) -- --
Interest expense (3.40) (7.20) -- --
Other income 135 139 -- --
Profit before tax 1,335 993 -- --
Taxes (338) (220) -- --
Tax rate (25) (22) -- --
Minorities and other -- -- -- --
Adj. profit 997 773 -- --
Exceptional items -- -- -- --
Net profit 997 773 -- --
yoy growth (%) 29 -- -- --
NPM 28.80 29.40 -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 - -
Profit before tax 1,335 993 -- --
Depreciation (99) (95) -- --
Tax paid (338) (220) -- --
Working capital 2,123 -- -- --
Other operating items -- -- -- --
Operating cashflow 3,021 -- -- --
Capital expenditure 82.90 -- -- --
Free cash flow 3,104 -- -- --
Equity raised 8,522 -- -- --
Investments -- -- -- --
Debt financing/disposal 9.03 -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 11,635 -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 - -
Equity capital 16.40 15.50 -- --
Preference capital -- -- -- --
Reserves 5,887 3,631 -- --
Net worth 5,903 3,646 -- --
Minority interest
Debt 4.07 4.96 -- --
Deferred tax liabilities (net) 79.90 80.10 -- --
Total liabilities 5,987 3,731 -- --
Fixed assets 1,292 1,157 -- --
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) 6.02 6.05 -- --
Net working capital 1,683 1,243 -- --
Inventories 1,275 756 -- --
Inventory Days 134 105 -- --
Sundry debtors 671 602 -- --
Debtor days 70.70 83.40 -- --
Other current assets 252 246 -- --
Sundry creditors (417) (268) -- --
Creditor days 44 37.10 -- --
Other current liabilities (98) (93) -- --
Cash 3,006 1,325 -- --
Total assets 5,987 3,731 -- --
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Mar-2020 - - -
Gross Sales 3,463 2,633 -- -- --
Excise Duty -- -- -- -- --
Net Sales 3,463 2,633 -- -- --
Other Operating Income -- -- -- -- --
Other Income 135 139 -- -- --
Total Income 3,598 2,772 -- -- --
Total Expenditure ** 2,161 1,678 -- -- --
PBIDT 1,437 1,095 -- -- --
Interest 3.41 7.18 -- -- --
PBDT 1,434 1,087 -- -- --
Depreciation 98.80 94.60 -- -- --
Minority Interest Before NP -- -- -- -- --
Tax 338 252 -- -- --
Deferred Tax 0.12 (32) -- -- --
Reported Profit After Tax 997 773 -- -- --
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 997 773 -- -- --
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 997 773 -- -- --
EPS (Unit Curr.) 63.10 49.90 -- -- --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 16.40 15.50 -- -- --
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 41.50 41.60 -- -- --
PBDTM(%) 41.40 41.30 -- -- --
PATM(%) 28.80 29.40 -- -- --
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity